Literature DB >> 8578526

The vascular biology of heart and lung preservation for transplantation.

D J Pinsky1.   

Abstract

In spite of optimal organ preservation techniques, the heart and the lungs remain extremely vulnerable to the ischemia and reperfusion which accompany the transplantation procedure. Following a period of prolonged preservation, the altered phenotype of the graft vasculature results in vasoconstriction, neutrophil sequestration, edema, and thrombosis in the reperfused graft. These parameters of vascular dysfunction translate into primary graft failure and recipient demise. Using endothelial cells exposed to hypoxia and reoxygenation as a simple paradigm for the vascular milieu during organ preservation/transplantation, we have found that second messenger pathways (cAMP and NO/cGMP) are suppressed, neutrophil-endothelial interactions are enhanced, and prothrombotic mechanisms are activated. Using heterotopic rat heart and orthotopic rat lung transplant models, we have shown that supplemention of second messenger pathways or interference with neutrophil-endothelial interactions can significantly enhance preservation. Understanding mechanisms of vascular dysfunction within the graft should help define clinically relevant therapeutic targets to enhance heart or lung preservation for transplantation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8578526

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  5 in total

1.  Expression of human CD46 modulates inflammation associated with GalTKO lung xenograft injury.

Authors:  L Burdorf; T Stoddard; T Zhang; E Rybak; A Riner; C Avon; A Laaris; X Cheng; E Sievert; G Braileanu; A Newton; C J Phelps; D Ayares; A M Azimzadeh; R N Pierson
Journal:  Am J Transplant       Date:  2014-04-02       Impact factor: 8.086

Review 2.  Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives.

Authors:  Jeng-Jiann Chiu; Shu Chien
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

3.  In vitro modeling of nonhypoxic cold ischemia-reperfusion simulating lung transplantation.

Authors:  Monica Casiraghi; Jason R Tatreau; John B Abano; John W Blackwell; Larry Watson; Keith Burridge; Scott H Randell; Thomas M Egan
Journal:  J Thorac Cardiovasc Surg       Date:  2009-09       Impact factor: 5.209

4.  Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction.

Authors:  Takekazu Iwata; Alexander Philipovskiy; Amanda J Fisher; Robert G Presson; Masako Chiyo; Jae Lee; Elizabeth Mickler; Gerald N Smith; Irina Petrache; David B Brand; William J Burlingham; Bagavathi Gopalakrishnan; Daniel S Greenspan; Jason D Christie; David S Wilkes
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

5.  Upregulation of P2Y2R, Active uPA, and PAI-1 Are Essential Components of Hantavirus Cardiopulmonary Syndrome.

Authors:  Virginie Bondu; Casey Bitting; Valerie L Poland; Joshua A Hanson; Michelle S Harkins; Sarah Lathrop; Kurt B Nolte; Daniel A Lawrence; Tione Buranda
Journal:  Front Cell Infect Microbiol       Date:  2018-05-23       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.